Envisagenics Raises Series A Financing To Scale Its Ai-Powered Rna Splicing Drug Discovery Platform
Round Type
Series A
New YorkBiotechnologyData And AnalyticsHealth CareScience And EngineeringArtificial IntelligenceDescription
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA splicing therapeutics, secured Series A financing to scale its drug discovery platform and biopharmaceutical partnerships. Red Cell Partners led the financing, which included investments from Microsoft's M12, Madrona Venture Group, Third Kind Venture Capital, Dynamk Capital, and Empire State Development's venture capital arm, New York Ventures.
Quick answer
Envisagenics raised an undisclosed amount in a Series A round, dated September 29, 2021. Envisagenics is based in New York, New York, United States.
- How much did Envisagenics raise?
- Envisagenics raised an undisclosed amount in a Series A round on September 29, 2021.
- What does Envisagenics do?
- Envisagenics is an AI-driven biotechnology company harnessing the therapeutic potential of RNA splicing.
- Where is Envisagenics based and how big is it?
- Envisagenics is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Envisagenics that raised within 45 days of this round, from Fundz verified event records.
- Exscientia raised $510M (Post-IPO Equity) on October 5, 2021.
- DeepCure raised $40M (Series A) on November 8, 2021.
- Cardurion Pharmaceuticals raised an undisclosed amount on October 27, 2021.
- American Bitcoin raised $18M on October 20, 2021.
- Delix Therapeutics raised $70M (Series A) on September 27, 2021.
- HealthSnap raised $5M on November 10, 2021.
Who to call at Envisagenics, and when
A new round usually means Envisagenics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Envisagenics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Envisagenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Envisagenics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Envisagenics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansEnvisagenics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.